The clinical development of recombinant human interleukin 11 (NEUMEGA™ rhIL-11 growth factor)

Stem Cells

Volumn 14, Issue SUPPL. 1, 1996, Pages 256-260

  Kaye, James A ^a  

^a PFIZER INC   (United States)

Author keywords

Chemotherapy; Cytokine; Interleukin 11 (iL 11); Megakaryocytopoiesis; Mucositis; Neoplasms; Recombinant human interleukin 11 (rhIL 11); Thrombocytopenia

Indexed keywords

GROWTH PROMOTOR; INTERLEUKIN 11; RECOMBINANT PROTEIN;

ADJUVANT CHEMOTHERAPY; BLOOD CELL COUNT; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DOSE RESPONSE; FEMALE; HUMAN; REVIEW; THROMBOCYTOPENIA;

BLOOD CELL COUNT; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GROWTH SUBSTANCES; HUMANS; INTERLEUKIN-11; RECOMBINANT PROTEINS; THROMBOCYTOPENIA;

EID: 17444441266     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.5530140733     Document Type: Article

References (26)

1. Musashi M, Yang Y-C, Paul SR et al. Direct and synergistic effects of interleukin 11 on murine hemopoiesis in culture. Proc Natl Acad Sci USA 1991;88:765-769.
2. Tsuji K, Lyman SD, Sudo T et al. Enhancement of murine hematopoiesis by synergistic interactions between steel factor (ligand for c-kit), interleukin-11, and other early acting factors in culture. Blood 1992;79:2855-2860.
3. 0 and entry into the cell cycle of primitive human hemopoietic progenitors. Proc Natl Acad Sci USA 1992;89:4013-4017.
4. -DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor. Exp Hematol 1993;21:1668-1672.
5. Tanaka R, Katayama N, Ohishi K et al. Accelerated cell-cycling of hematopoietic progenitor cells by growth factors. Blood 1995;86:73-79.
6. Hirayama F, Shih J-P, Awgulewitsch A et al. Clonal proliferation of murine lymphohemopoietic progenitors in culture. Proc Natl Acad Sci USA 1992;89:5907-5911.
7. Neben S, Donaldson D, Sieff C et al. Synergistic effects of interleukin-11 with other growth factors on the expansion of murine hematopoietic progenitors and maintenance of stem cells in liquid culture. Exp Hematol 1994;22:353-359.
8. Paul SR, Bennett F, Calvetti JA et al. Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc Natl Acad Sci USA 1990;87:7512-7516.
9. Bruno E, Briddell RA, Cooper RJ et al. Effects of recombinant interleukin 11 on human megakaryocyte progenitor cells. Exp Hematol 1991;19:378-381.
10. Yonemura Y, Kawakita M, Masuda T et al. Synergistic effects of interleukin 3 and interleukin 11 on murine megakaryopoiesis in serum-free culture. Exp Hematol 1992;20:1011-1016.
11. Teramura M, Kobayashi S, Hoshino S et al. Interleukin-11 enhances human megakaryocytopoiesis in vitro. Blood 1992;79:327-331.
12. Neben TY, Loebelenz J, Hayes L et al. Recombinant human interleukin-11 stimulates megakaryocytopoiesis and increases peripheral platelets in normal and splenectomized mice. Blood 1993;81:901-908.
13. Leonard JP, Quinto CM, Kozitza MK et al. Recombinant human interleukin-11 stimulates multilineage hematopoietic recovery in mice after a myelosuppressive regimen of sublethal irradiation and carboplatin. Blood 1994;83:1499-1506.
14. Maze R, Moritz T, Williams DA. Increased survival and multilineage hematopoietic protection from delayed and severe myelosuppressive effects of a nitrosourea with recombinant interleukin-11. Cancer Res 1994;54:4947-4951.
15. Hangoc G, Yin T, Cooper S et al. In vivo effects of recombinant interleukin-11 on myelopoiesis in mice. Blood 1993;81:965-972.
16. Goldman SJ. Preclinical biology of interleukin 11: a multifunctional hematopoietic cytokine with potent thrombopoietic activity. STEM CELLS 1995;13:462-471.
17. Du XX, Neben T, Goldman S et al. Effects of recombinant human interleukin-11 on hematopoietic reconstitution in transplant mice: acceleration of recovery of peripheral blood neutrophils and platelets. Blood 1993;81:27-34.
18. ™ rhIL-11 growth factor) in women with breast cancer receiving chemotherapy. Blood 1996;87:3615-3624.
19. ™ rhIL-11 growth factor) increases plasma volume and decreases urine sodium excretion in normal human subjects. Blood 1994;84(suppl 1):276a.
20. ™ rhIL-11 growth factor) in patients with severe chemotherapy-induced thrombocytopenia. Blood 1996;87:3607-3614.
21. Pisciotto PT, Benson K, Hume H et al. Prophylactic versus therapeutic platelet transfusion practices in hematology and/or oncology patients. Transfusion 1995;35:498-502.
22. ™ rhIL-11 growth factor) increases plasma von Willebrand factor and fibrinogen concentrations in normal human subjects. Blood 1994;84(suppl 1):276a.
23. Sonis S, Muska A, O'Brien J et al. Alteration in the frequency, severity and duration of chemotherapy-induced mucositis in hamsters by interleukin-11. Oral Oncology 1995;31B(4):261-266.
24. Potten CS. Interleukin-11 protects the clonogenic stem cells in murine small-intestinal crypts from impairment of their reproductive capacity by radiation. Int J Cancer 1995;62:356-361.
25. Peterson RL, Trepicchio WL, Bozza MM et al. G1 growth arrest and reduced proliferation of intestinal epithelial cells induced by rhIL-11 may mediate protection against mucositis. Blood 1995;86(suppl 1):311a.
26. Trepicchio WL, Bozza M, Dorner AJ. Recombinant human interleukin-11 attenuates the inflammatory response through downregulation of proinflammatory cytokine production and nitric oxide release. Blood 1995;86(suppl 1):424a.